Updated mechanism of multidrug ABC transporters from Bacillus - - PowerPoint PPT Presentation

updated mechanism of multidrug abc transporters from
SMART_READER_LITE
LIVE PREVIEW

Updated mechanism of multidrug ABC transporters from Bacillus - - PowerPoint PPT Presentation

10th French-Belgian ABC meeting Brussels, Belgium, October 19-20, 2012 Updated mechanism of multidrug ABC transporters from Bacillus subtilis Jean-Michel Jault (Institut de Biologie Structurale, Grenoble, France) ABC ( A A TP- B B inding


slide-1
SLIDE 1

10th French-Belgian ABC meeting Brussels, Belgium, October 19-20, 2012

‘Updated’ mechanism of multidrug ABC transporters from Bacillus subtilis

Jean-Michel Jault (Institut de Biologie Structurale, Grenoble, France)

slide-2
SLIDE 2

ABC (“A ATP-B Binding C Cassette”) Transporters

  • Family of ubiquitous transporters, importers + exporters: ˜ 25 000 / 71 659

(Transporter DataBase) Ren et al (2007) NAR

  • Modular Structure : 4 core domains ( + 1 substrate binding protein for importers).

Membrane

B C D F P P Q M A J

Lipid A

MsbAMsbA

Outside Inside

  • ligopeptide

histidine Multiple drugs Chloride ion

Membrane P-gp CFTR TAP 1 TAP 2

Peptides Multiple drugs

BmrA BmrA

Multiple drugs

BmrCBmrD

slide-3
SLIDE 3

Structure of the homo-dimer of 2 NBDs : the transient ‘sandwich’ dimer

The inactive mutant traps 2 ATP molecules at the interface of the 2 NBDs

Walker A Walker A ABC ABC

D D C E

lipoproteins

Mb Out In

LolD subunit

Conserved Conserved motifs : motifs :

  Walker

Walker A & B A & B: : ATP ATP

  H

H & & Q Q: : ATP ATP

  ABC

ABC signature signature ==> ==> ATP ATP too too

NBD1 NBD2

Smith (2002) Mol Cell

slide-4
SLIDE 4

Structure of the homo-dimer of 2 NBDs : the transient ‘sandwich’ dimer

The inactive mutant traps 2 ATP molecules at the interface of the 2 NBDs

Walker A Walker A ABC ABC

D D C E

lipoproteins

Mb Out In

LolD subunit

Conserved Conserved motifs : motifs :

  Walker

Walker A & B A & B: : ATP ATP

  H

H & & Q Q: : ATP ATP

  ABC

ABC signature signature ==> ==> ATP ATP too too

NBD1 NBD2

Smith (2002) Mol Cell

slide-5
SLIDE 5

2006: 3-D structure of a bacterial ABC MDR 2006: 3-D structure of a bacterial ABC MDR transp transp. .

ICD1 ICD2 3 sub-domains :

  • NBD
  • TMD (6 TMH / monomer)
  • ICD1 (TMH 2 and 3) interacts in cis but

ICD2 (TMH 4 and 5) interacts in trans :

  • ut

in

Multiple Drugs

Sav 1866 Sav 1866

mb

ATP ATP

mb

NBD

Dawson & Locher (2006) Nature

TMD TMD TMD NBD NBD NBD NBD ICD ICD ICD ICD

1 2 1 2

TMD TMD domain swapping of ICD2

slide-6
SLIDE 6

3 conformations of 3 conformations of MsbA MsbA

Open apo Closed apo

Ward et al (2007) PNAS

~ 50 Å

  • ut

in mb

Lipid A

MsbAMsbA

mb

  • ut

in

+ ATP ICD ICD ICD ICD

1 2 1 2

ICD ICD ICD ICD

1 2 1 2

ICD ICD ICD ICD 1

2 1 2

Closed ATP-bound (or ADP-Vi)

Rigid body motion

slide-7
SLIDE 7

Are these open conformations physiologically relevant ?

Open apo P-gp Open apo EcMsbA … “Thus, the structure may represent a crystallization artifact or a nonfunctional conformation that has only very transient existence”. ICD ICD ICD ICD

1 2 1 2 Aller et al. (2009) Science

slide-8
SLIDE 8

Overexpression of BmrA and purification

  • Purification in a single step

(Ct-polyhistidine-tagged) ~2-3 mg of BmrA/Liter

Orelle et al. (2003) JBC

Hoechst 33342 ATP ADP + Pi

25 50 75 100 200 400 600 Time (sec.) Normalized fluorescence (%) 1 2 3 kDa 94 67 43 30

ATP

Hoechst

  • Inside-out membrane vesicles:

BmrA ~ 50% of mb proteins

Steinfels et al. (2002) BBA

Multiple drugs

BmrA BmrA

slide-9
SLIDE 9

Time

MW

Time

119 79 46 31

5’ 15’ 30’ 1h 2h 3h C

C

5’ 15’ 30’ 1h 2h 3h

Membrane Apo Vi-inhibited

Apo Vi-inhibited

Time C

MW

24 19 119 79 46 31

5’ 15’ 30’ 5’ 15’ 30’

DDM purified

Behavior of BmrA in membrane or in detergent : 2 different conformations ?

The Vi-inhibited BmrA is much less sensitive to limited digestion by trypsin than BmrA in the resting state. ==> BmrA switches between two very different conformations in mb or in detergent

slide-10
SLIDE 10

Are the two BmrA conformations really ‘stable’ ? Rigid body motion ?

interac(on
between
TMD
(ICD)
&
NBD
similar
in
open
or
closed
state

slide-11
SLIDE 11

The H/D exchange technique

H : Do not exchange H : Too fast to be monitored H : Best candidates for deuterium exchange; exchange rate depends on structure and accessibility

  • Different types of hydrogen in proteins

D D D

slide-12
SLIDE 12

The H/D exchange technique

H : Do not exchange H : Too fast to be monitored H : Best candidates for deuterium exchange; exchange rate depends on structure and accessibility

  • Different types of hydrogen in proteins

D D D

Labeling quench

H+, 0°C

Obtain peptides to locate D Proteolysis H/D exchange kinetics Labeled region

Exchange H D Dilution D2O 1- Global kinetics HPLC MS

Separate peptides Mass measurement of each peptide 2- Local kinetics Time (sec) Deuteration (%)

slide-13
SLIDE 13

TMD : poorly defined, but ICDs OK NBD : well defined

sequence coverage

Total : 78% using pepsin

NBD 1 2 3 4 5 6 NBD

ICD1 ICD2

TMD NBD

slide-14
SLIDE 14

Portfolio of different peptides

WT Apo E504A (ATPase inactive) + ATP/Mg

slide-15
SLIDE 15

20 40 60 80 15 60 300 600 1800 3600 Time
(s)

%
H/D
Exchange

Open Closed

372-383 Walker A

Few examples : Walker A motif

Protection by ATP

slide-16
SLIDE 16

20 40 60 80 15 60 300 600 1800 3600 Time
(s)

%
H/D
Exchange

Open Closed

479-492 ABC motif Protection by ATP

ABC signature peptide

slide-17
SLIDE 17

20 40 60 80 15 60 300 600 1800 3600 Time
(s)

%
H/D
Exchange

Open Closed

501-509 Walker B

Walker B motif

Protection by ATP

slide-18
SLIDE 18

20 40 60 80 15 60 300 600 1800 3600

Time
(s) %
H/D
Exchange

Open Closed

104-114 ICD 1

Peptide from ICD1 (cis with its own NBD)

slide-19
SLIDE 19

20 40 60 80 15 60 300 600 1800 3600 Time
(s)

%
H/D
Exchange

Open Closed

203-215 ICD 2

Peptide from ICD2 (trans with the other NBD)

slide-20
SLIDE 20

20 40 60 80 15 60 300 600 1800 3600 Time
(s)

%
H/D
Exchange

Open Closed

216-236 ICD 2

2nd Peptide from ICD2 (trans with the other NBD)

slide-21
SLIDE 21

Poorly exchangeable OK with 3D structure Highly exchangeable, especially for ICDs Different from 3D structure Greater flexibility of ICDs Reorientation of the NBDs and/or unfolding

slide-22
SLIDE 22

Conclusions from H/D exchange

  • Similar behavior of BmrA in membrane and purified in DDM
  • BmrA switches between two conformations :
  • Resting state : open conformation (high H/D exchange)
  • ATP-bound state : closed conformation (low H/D exchange)
  • In the resting state, the ICDs and in particular ICD2, are

highly flexible ==> ICDs disengaged from the NBD ==> different orientation and/or unfolding of the NBD ==> ≠ 3D structure of EcMsbA (rigid body motion) ==> Can this flexibility help to recognize many substrates ?

Mehmood et al (2012) PNAS

slide-23
SLIDE 23

Is this flexibility of the ICDs restricted to BmrA ?

Multiple drugs

BmrCBmrD

BmrC/BmrD model based on the TM heterodimer (Seeger’s group)

Heterodimer with asymmetric NBDs (MRP, CFTR, TAP1/TAP2…)

slide-24
SLIDE 24

..even in the resting state Multidrug ABC transporters need to…

slide-25
SLIDE 25

IBCP, Lyon

Vincent Chaptal Pierre Falson Attilio Di Pietro

Many thanks to….

Our team in IBS

Shahid Mehmood Jonathan Sarwan Benjamin Wiseman Emilie Boncoeur Eric Forest

  • Univ. Oxford, UK

Carmen Domene